Molecular Characteristics of Chinese Patients with TSC2-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study

被引：0
|
作者：
Huang, Z. [1 ]
Xu, C. [1 ]
Wang, W. [2 ]
Zhang, Q. [3 ]
Zhuang, W. [1 ]
Zhu, Y. [4 ]
Chen, Y. [1 ]
Chen, G. [1 ]
Fang, M. [2 ]
Lv, T. [5 ]
Song, Y. [6 ]
机构：
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[4] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China
[5] Jinling Hosp, Resp, Nanjing, Jiangsu, Peoples R China
[6] Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
TSC2; mutation; Non-small-cell lung cancer; Prognosis;
D O I：
10.1016/j.jtho.2018.08.684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-03
引用
收藏
页码：S512 / S513
页数：2
相关论文
共 50 条
  • [21] Molecular Spectrum of Patients with MSH2 Mutations in Chinese Non-Small Cell Lung Cancer
    Wang, W.
    Xu, C.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Chen, Y.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S719 - S719
  • [22] Molecular targeted therapy of patients with non-small-cell lung cancer
    Stencel, Katarzyna
    Swiniuch, Daria
    Ramlau, Rodryg
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (06): : 289 - 296
  • [23] The Molecular Landscape and Outcome of Chinese Patients with Non-Small Cell Lung Cancer Harboring NTRK1 Point Mutations: A Retrospective Study
    Chen, X.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Chen, Y.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S520 - S521
  • [24] Clinical characteristics associated with non-small-cell lung cancer harboring ALK rearrangements in Chinese patients
    Tian, Guangming
    Zhao, Xinliang
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Zhang, Jie
    Chen, Xiaoling
    Han, Jindi
    Ma, Xiangjuan
    Wu, Di
    Han, Sen
    Long, Jieran
    Wang, Yang
    Fang, Jian
    FUTURE ONCOLOGY, 2016, 12 (10) : 1243 - 1249
  • [25] Clinicopathologic Characteristics and Outcomes of Chinese Patients with Non-Small-Cell Lung Cancer and INPP4B Mutations
    Yang, D.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Z.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S958 - S959
  • [26] Analysis of ESR1 Mutation Spectrum from Non-Small-Cell Lung Cancer in Chinese Patients
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Y.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S913 - S913
  • [27] Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study
    Chen, Xiaofeng
    Zhu, Quan
    Liu, Yiqian
    Liu, Ping
    Yin, Yongmei
    Guo, Renhua
    Lu, Kaihua
    Gu, Yanhong
    Liu, Lianke
    Wang, Jinghua
    Wang, Zhaoxia
    Roe, Oluf Dimitri
    Shu, Yongqian
    Zhu, Lingjun
    PLOS ONE, 2014, 9 (05):
  • [28] Molecular pathology of non-small-cell lung cancer
    Breuer, RHJ
    Postmus, PE
    Smit, EF
    RESPIRATION, 2005, 72 (03) : 313 - 330
  • [29] Molecular Markers of Various Stages of Non-Small-Cell Lung Cancer
    I. B. Zborovskaya
    A. G. Tatosyan
    Molecular Biology, 2004, 38 : 155 - 164
  • [30] Molecular markers of various stages of non-small-cell lung cancer
    Zborovskaya, IB
    Tatosyan, AG
    MOLECULAR BIOLOGY, 2004, 38 (02) : 155 - 164
12345